Story · Medicine & Biotech
Diabetes Australia welcomes new oral GLP-1 treatment option for Australians
1 outlet · first reported by Diabetes Australia 6d ago
Coverage, in order
-
6d ago
Diabetes Australia welcomes new oral GLP-1 treatment option for AustraliansDiabetes Australia welcomes the Therapeutic Goods Administration’s (TGA) recent approval of a new oral formulation of Wegovy (semaglutide) as a step forward in the treatment of obesity and related chronic conditions. The oral formulation – in pill or tablet form – is an alternative delivery form to…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.